PharmaMénta Aps

Past relations

Ultimate beneficial owners (UBOs): Jimmi Javed Christensen Malik
2019-07-01 – 33% ownership (2019-07-01 – ) 33% voting rights (2019-07-01 – )

Torben Hvingelby Pedersen
2001-01-03 – 34% ownership (2019-07-01 – ) 100% ownership (2001-01-03 – 2019-06-30 ) 34% voting rights (2019-07-01 – ) 100% voting rights (2001-01-03 – 2019-06-30 )

Lasse Hvingelby Kikkenborg
2019-07-01 – 33% ownership (2019-07-01 – ) 33% voting rights (2019-07-01 – )
Legal owners: Torben Hvingelby Pedersen
2001-01-03 – 33.33% ownership (2001-01-03 – ) 33.33% voting rights (2001-01-03 – )

LHK Holding Esbjerg ApS 25% ownership (2019-07-01 – ) 25% voting rights (2019-07-01 – )

JMINT Holding ApS 25% ownership (2019-07-01 – ) 25% voting rights (2019-07-01 – )
Directors: Jimmi Javed Christensen Malik
2019-02-22 –

Torben Hvingelby Pedersen
2008-07-01 – 2019-02-22

Nina Margrethe Egtved Knudsen
2007-10-01 – 2008-07-01

Steen Schierbeck
2000-09-15 – 2001-01-03
Board members: Jimmi Javed Christensen Malik
2019-02-22 –

Torben Hvingelby Pedersen
2004-08-09 –

Lasse Hvingelby Kikkenborg
2012-12-21 –

Tom Krongaard Thomsen
2012-12-21 – 2019-02-22

Jørgen Makholm
2004-08-09 – 2012-12-21

Janus Hvingelby Kikkenborg
2009-05-27 – 2012-12-21

Max Terpager
2004-08-09 – 2009-09-28

PharmaMénta Aps has 2.00 full time equivalents (FTEs) and 2.00 employees as of 1 May, 2025.

Revenue

Profit/loss

'000	12-2012	12-2013	12-2014	12-2015	12-2016	12-2017
Currency	DKK	DKK	DKK	DKK	DKK	DKK
Revenue	0	0	0	0	0	0
Raw materials and consumables used	0	0	0	0	0	0
Other external expenses	0	0	0	0	0	0
Gross profit loss	-6	-7	0	126	1,343	1,120
Employee benefits expense	0	0	0	0	0	0
Wages and salaries	0	0	0	0	0	0
Depreciation amortisation expense and impairment losses of prop	0	0	0	0	0	0
Profit loss from ordinary operating activities	-6	-7	164	126	1,343	-4,880
Profit loss from ordinary activities before tax	225	183	164	261	1,476	-4,891
Other finance expenses	0	0	2	0	0	11
Tax expense	0	48	38	57	326	0
Profit loss	286	136	125	204	1,150	-5,138